All data must be read in conjunction with the survey limitations Part of the reasoning behind introducing the questions about a respondent's functionality was to see if the ratings of functionality provided a better relationship to the other factors, like type of drug and length of use, than the rating of the severity of a respondents symptoms. There is a fairly strong relationship between functionality and severity of symptoms for these respondents. As the average severity of symptoms increased the average rating of functionality goes down, as one might expect. For instance those who rated their symptoms between nothing and mild reported that they were, on average able to participate in around 7 of the 9 activities with ease, compared with those who were experiencing moderate to severe symptoms who were only able to participate, on average, in around one activity. In each of the symptoms groups there was still quite a variation in the number of activities that were able to do done with ease. Some respondents said that despite their symptoms being between moderate and severe, they were able to participate in 7 activities with ease.
The relationship between functionality rating and age, type of drug, time on the drug and dose size was investigated. The only one where a minor trend may have been seen for these respondent's, was that between functionality and dose size. This is shown in the graphs below, taken at two points in the benzo journey. There seems to be a tendency towards less functionality being experienced by those on higher doses. This trend notably reversed by those in the 80 - 100mg group.
|
Disclaimer: The information contained in this website was not compiled by a doctor or anyone with medical training. The advice contained herein should not be substituted for the advice of a physician who is well-informed in the subject matter discussed. Before making any decisions about your health or treatment you should always confer with your physician and it is always assumed that you will do so. About this site Disclaimer Contact Last updated 21 July 2020
|